Inventor · disambiguated record
Stephen J. Galli
Also filed as: GALLI STEPHEN · GALLI STEPHEN J
14 granted patents·3 pending applications·273 citations·filing 1991–2020
93Inventor score
Files withBETH ISRAEL HOSPITAL10UNIV LELAND STANFORD JUNIOR3INST NAT SANTE RECH MED2ARCTURUS PHARM CORP1PILIPONSKY ADRIAN MARTIN1
Top patents by PatentIndex Score
17 records- 0186US11656233B2Multiplex isotype-specific antibody detectionUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted May 23, 2023·4 cites·16 claims
- 0282US5703088ATopical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responsesBETH ISRAEL HOSPITAL·Filed 1992·Granted Dec 30, 1997·72 cites·20 claims
- 0372US6500942B1Rin2, a novel inhibitor of Ras-mediated signalingBETH ISRAEL HOSPITAL·Filed 2000·Granted Dec 31, 2002·4 cites·45 claims
- 0471US5637314ATopical and systemic application of buspirone or derivatives thereof for treating atopic dermatitisBETH ISRAEL HOSPITAL·Filed 1995·Granted Jun 10, 1997·37 cites·32 claims
- 0570US5631017ATopical application of buspirone for treatment of pathological conditions associated with immune responsesBETH ISRAEL HOSPITAL·Filed 1993·Granted May 20, 1997·39 cites·12 claims
- 0666US5244902ATopical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responsesBETH ISRAEL HOSPITAL·Filed 1992·Granted Sep 14, 1993·28 cites·12 claims
- 0763US5693645AUse of spiperone or spiperone derivatives as immunosuppressant agentsBETH ISRAEL HOSPITAL·Filed 1992·Granted Dec 2, 1997·29 cites·21 claims
- 0858US5637616AMethod for treating diseases mediated by proteasesARCTURUS PHARM CORP·Filed 1993·Granted Jun 10, 1997·29 cites·48 claims
- 0953US8449864B2Neurotensin as a marker and therapeutic target for sepsisPILIPONSKY ADRIAN MARTIN·Filed 2007·Granted May 28, 2013·1 cites·3 claims
- 1053US5290783AUse of spiperone derivatives as immunosuppressant agentsBETH ISRAEL HOSPITAL·Filed 1991·Granted Mar 1, 1994·13 cites·8 claims
- 1152US2022227859A1Method to treat type 2 inflammation or mast-cell dependent diseaseINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 1250US7365239B2In vivo models for rabGEF1-dependent signaling and functionsUNIV LELAND STANFORD JUNIOR·Filed 2005·Granted Apr 29, 2008·0 cites·2 claims
- 1347US2010092974A1Methods for screening for modulators of ccrl2UNIV LELAND STANFORD JUNIOR·Filed 2009·Application pending·0 cites
- 1441US5965707ARin2, a novel inhibitor of Ras-mediated signalingBETH ISRAEL HOSPITAL·Filed 1997·Granted Oct 12, 1999·4 cites·8 claims
- 1540US5574041AUse of spiperone derivatives as immunosuppressant agentsBETH ISRAEL HOSPITAL·Filed 1992·Granted Nov 12, 1996·8 cites·38 claims
- 1636US5639758ATopical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responsesBETH ISRAEL HOSPITAL·Filed 1993·Granted Jun 17, 1997·5 cites·3 claims
- 1736US2020011865A1Methods and kits for detecting basophil activationINST NAT SANTE RECH MED·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen J. Galli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →